《房颤和卒中》课件.pptVIP

卒中风险评估和分层防治论坛;房颤双重抗血小板治疗预防卒中的新契机－ACTIVE A的启示;房颤与卒中的发生;不同国家的房颤患病率;房颤患者卒中危险分层;房颤相关性缺血性脑卒中的危害;Background Anticoagulation with an INR below 2.0 is not effective Increased risk for bleeding complications with an INR 3.5 Patients 65 years of age with “lone AF” (without other risk factors) are at low risk, whereas patients older than 65 years are at a higher risk for embolic stroke Anticoagulation can be safe and effective in older individuals1, 2 ;维生素K拮抗剂用于房颤;中国AF患者抗凝治疗的现状;抗血小板治疗用于AF患者;ACTIVE研究的设计与流程;ACTIVE W 研究;ACTIVE A 研究结果;ACTIVE A入组情况的因素;研究总结;;氯吡格雷加ASA与单用ASA相比，可显著减少11%的血管事件相对风险;在卒中方面的获益最大;一级和